
InMode Ltd. INMD
$ 13.57
-0.62%
Annual report 2025
added 03-14-2026
InMode Ltd. Accounts Payables 2011-2026 | INMD
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables InMode Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.9 M | 13.8 M | 14 M | 16.2 M | 8.78 M | 6.41 M | 3.7 M | 4.51 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.9 M | 3.7 M | 10.7 M |
Quarterly Accounts Payables InMode Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 8.78 M | - | - | - | 6.41 M | - | - | - | 3.7 M | - | - | - | 4.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.78 M | 3.7 M | 5.85 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
535 K | $ 2.21 | -0.43 % | $ 3.45 M | ||
|
Alphatec Holdings
ATEC
|
40.9 M | $ 12.93 | -0.92 % | $ 1.94 B | ||
|
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 10.53 | 0.77 % | $ 1.42 B | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 9.69 | -13.17 % | $ 274 M | ||
|
Cytosorbents Corporation
CTSO
|
3.34 M | $ 0.66 | -2.96 % | $ 35.9 M | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.82 | -5.91 % | $ 142 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Cognyte Software Ltd.
CGNT
|
25.2 M | $ 8.32 | -0.48 % | $ 597 M | ||
|
Establishment Labs Holdings
ESTA
|
43.1 M | $ 65.54 | 0.81 % | $ 1.94 B | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 4.06 | -4.92 % | $ 859 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
1.14 B | $ 70.78 | -0.59 % | $ 105 B | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 37.4 | 0.16 % | $ 1.16 B | ||
|
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | ||
|
IRIDEX Corporation
IRIX
|
4.5 M | $ 1.33 | - | $ 21.5 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 16.8 | -2.38 % | $ 394 M | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.44 | -0.05 % | $ 121 M | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | ||
|
Abbott Laboratories
ABT
|
4.24 B | $ 109.06 | -1.49 % | $ 190 B | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 9.49 | -2.57 % | $ 340 M | ||
|
Bio-Rad Laboratories
BIO
|
122 M | $ 269.13 | -0.13 % | $ 7.59 B | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 2.07 | -4.61 % | $ 1.26 M | ||
|
AxoGen
AXGN
|
2.89 M | $ 31.04 | -5.22 % | $ 1.43 B | ||
|
Align Technology
ALGN
|
109 M | $ 172.05 | -2.31 % | $ 12.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
82.5 M | $ 8.93 | -1.92 % | $ 688 M | ||
|
Bruker Corporation
BRKR
|
234 M | $ 34.17 | 1.27 % | $ 5.09 K | ||
|
Apyx Medical Corporation
APYX
|
3.06 M | $ 3.74 | -0.13 % | $ 154 M | ||
|
Second Sight Medical Products
EYES
|
817 K | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
34 M | $ 0.39 | -0.46 % | $ 40.1 M | ||
|
IRadimed Corporation
IRMD
|
1.82 M | $ 101.34 | -1.42 % | $ 1.29 B |